Risk of secondary haematological malignancies in patients with follicular lymphoma: an analysis of 1028 patients treated in the rituximab era

Autor: Prusila, R. E. (Roosa E. I.), Sorigue, M. (Marc), Jauhiainen, J. (Jyrki), Mercadal, S. (Santiago), Postila, A. (Aleksi), Salmi, P. (Petteri), Tanhua, T. (Taru), Tikkanen, S. (Susanna), Kakko, S. (Sakari), Kuitunen, H. (Hanne), Pollari, M. (Marjukka), Nystrand, I. (Ilja), Kuusisto, M. E. (Milla E. L.), Vasala, K. (Kaija), Jantunen, E. (Esa), Korkeila, E. (Eija), Karihtala, P. (Peeter), Sancho, J. (Juan‐Manuel), Turpeenniemi‐Hujanen, T. (Taina), Kuittinen, O. (Outi)

Publikováno v: British Journal of Haematology
r-IGTP. Repositorio Institucional de Producción Científica del Instituto de Investigación Germans Trias i Pujol
instname

Follicular lymphoma (FL) is the most common indolent lymphoma. Currently there are many comparable treatment options available for FL. When selecting the most optimal therapy it is important to consider possible late effects of the treatment as well

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=dedup_wf_001::207fb7a1e225966ac134639fc2db5fd4
https://fundanet.igtp.cat/Publicaciones/ProdCientif/PublicacionFrw.aspx?id=3184

Incidence of solid cancer in patients with follicular lymphoma.

Autor: Sorigue M; Department of Hematology, ICO-Hospital Germans Trias i Pujol, Institut de Recerca Josep Carreras, Barcelona, Spain., Prusila REI; Medical Research Center, Oulu University Hospital and Cancer and Translational Research Unit, University of Oulu, Oulu, Finland.; Department of Oncology and Radiotherapy, Oulu University Hospital, Oulu, Finland., Jauhiainen J; Department of Applied Physics, University of Eastern Finland, Kuopio, Finland., Mercadal S; Department of Hematology, ICO-Hospital Duran i Reynals, Hospitalet de Llobregat, Spain., Postila A; Medical Research Center, Oulu University Hospital and Cancer and Translational Research Unit, University of Oulu, Oulu, Finland.; Department of Oncology and Radiotherapy, Oulu University Hospital, Oulu, Finland., Salmi P; Medical Research Center, Oulu University Hospital and Cancer and Translational Research Unit, University of Oulu, Oulu, Finland.; Department of Oncology and Radiotherapy, Oulu University Hospital, Oulu, Finland., Tanhua T; Medical Research Center, Oulu University Hospital and Cancer and Translational Research Unit, University of Oulu, Oulu, Finland.; Department of Oncology and Radiotherapy, Oulu University Hospital, Oulu, Finland., Tikkanen S; Medical Research Center, Oulu University Hospital and Cancer and Translational Research Unit, University of Oulu, Oulu, Finland.; Department of Oncology and Radiotherapy, Oulu University Hospital, Oulu, Finland., Kakko S; Department of Oncology and Radiotherapy, Oulu University Hospital, Oulu, Finland., Kuitunen H; Medical Research Center, Oulu University Hospital and Cancer and Translational Research Unit, University of Oulu, Oulu, Finland.; Department of Oncology and Radiotherapy, Oulu University Hospital, Oulu, Finland., Pollari M; Department of Oncology, Tampere University Hospital, Tampere, Finland., Nystrand I; Department of Oncology, University of Turku and Turku University Hospital, Turku, Finland., Kuusisto MEL; Medical Research Center, Oulu University Hospital and Cancer and Translational Research Unit, University of Oulu, Oulu, Finland.; Siunsote - Hospital District of North Carelia, Joensuu, Finland., Vasala K; Department of Oncology and Radiotherapy, Central Finland Central Hospital, Jyvaskyla, Finland., Jantunen E; Siunsote - Hospital District of North Carelia, Joensuu, Finland.; Department of Medicine, Kuopio University Hospital, Kuopio, Finland.; Institute of Clinical Medicine, Faculty of Health Medicine, University of Eastern Finland, Kuopio, Finland., Korkeila E; Department of Oncology, University of Turku and Turku University Hospital, Turku, Finland., Karihtala P; Medical Research Center, Oulu University Hospital and Cancer and Translational Research Unit, University of Oulu, Oulu, Finland.; Department of Oncology and Radiotherapy, Oulu University Hospital, Oulu, Finland., Sancho JM; Department of Hematology, ICO-Hospital Germans Trias i Pujol, Institut de Recerca Josep Carreras, Barcelona, Spain., Turpeenniemi-Hujanen T; Medical Research Center, Oulu University Hospital and Cancer and Translational Research Unit, University of Oulu, Oulu, Finland.; Department of Oncology and Radiotherapy, Oulu University Hospital, Oulu, Finland., Kuittinen O; Department of Oncology and Radiotherapy, Oulu University Hospital, Oulu, Finland.; Institute of Clinical Medicine, Faculty of Health Medicine, University of Eastern Finland, Kuopio, Finland.; Department of Oncology, Kuopio University Hospital, Kuopio, Finland.

Publikováno v: Acta oncologica (Stockholm, Sweden) [Acta Oncol] 2019 Nov; Vol. 58 (11), pp. 1564-1569. Date of Electronic Publication: 2019 Aug 01.